Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Trans-resveratrol

EU orphan designation number: EU/3/16/1827   
Active ingredient: Trans-resveratrol
Indication: Treatment of spinocerebellar ataxia
Sponsor: Luis Pereira de Almeida
CNC- Center for Neuroscience and Cell Biology, Ed. Fac. Medicina, Rua Larga, University of Coimbra, Portugal

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/01/2017 Orphan designation EMA/OD/209/16 (2017)232 of 12/01/2017